Advisory Services Network’s Haemonetics HAE Stock Holding History

Advisory Services Network’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$789	Buy	+14	New	+$912	﹤0.01%	4355
2025 Q4	–	Sell	-9	Closed	-$439	–	2858
2025 Q3	$439	Buy	+9	New	+$557	﹤0.01%	4069
2024 Q1	–	Sell	-293	Closed	-$25.1K	–	2375
2023 Q4	$25.1K	Buy	+293	New	+$25.3K	﹤0.01%	2400
2023 Q2	–	Sell	-277	Closed	-$22.9K	–	2362
2023 Q1	$22.9K	Buy	277 +7	+3%	+$567	﹤0.01%	2464
2022 Q4	$21.2K	Buy	+270	New	+$21.7K	﹤0.01%	2437
2021 Q4	–	Sell	-3,025	Closed	-$214K	–	1440
2021 Q3	$214K	Sell	3,025 -156	-5%	-$9.84K	0.01%	1240
2021 Q2	$212K	Buy	+3,181	New	+$225K	0.01%	1237
2021 Q1	–	Sell	-322	Closed	-$38K	–	1991
2020 Q4	$38K	Sell	322 -60	-16%	-$6.46K	﹤0.01%	1817
2020 Q3	$33K	Buy	+382	New	+$33.4K	﹤0.01%	1791
2020 Q2	–	Sell	-96	Closed	-$9K	–	1743
2020 Q1	$9K	Hold	96	–	–	﹤0.01%	2232
2019 Q4	$11K	Buy	96 +14	+17%	+$1.69K	﹤0.01%	2307
2019 Q3	$10K	Hold	82	–	–	﹤0.01%	2149
2019 Q2	$10K	Buy	+82	New	+$8.07K	﹤0.01%	2147

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisory Services Network's HAE Position: Q1 2026 in Review

Advisory Services Network opened a new position in Haemonetics (HAE) in Q1 2026: 14 shares worth $789. The stake represents ﹤0.01% of the portfolio and ranks #4355 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in HAE as recently as Q3 2025.

Advisory Services Network first reported a position in HAE in Q2 2019 and has held it in 13 quarters since. The position peaked at $214K in Q3 2021. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Advisory Services Network held 14 shares of Haemonetics worth $789 as of Q1 2026.
Haemonetics was a new Advisory Services Network position in Q1 2026.
Haemonetics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4355 holding.
Advisory Services Network first reported a position in Haemonetics in Q2 2019 and has held it in 13 quarters since.
Advisory Services Network's Haemonetics position peaked at $214K in Q3 2021.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.